Sequenom Faces Class Action Lawsuits

Law firms have started filing class action suits against Sequenom on behalf of shareholders following the firm's announcement earlier this week that R&D data for its SEQureDx Down syndrome test had been mishandled by employees.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.